These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 12830927)

  • 1. The role of peptides in treatment of psychiatric disorders.
    Holsboer F
    J Neural Transm Suppl; 2003; (64):17-34. PubMed ID: 12830927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropeptides and neuropeptide receptors: drug targets, and peptide and non-peptide ligands: a tribute to Prof. Dieter Seebach.
    Hoyer D; Bartfai T
    Chem Biodivers; 2012 Nov; 9(11):2367-87. PubMed ID: 23161624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of neuropeptide systems in schizophrenia: human studies.
    Cáceda R; Kinkead B; Nemeroff CB
    Int Rev Neurobiol; 2007; 78():327-76. PubMed ID: 17349866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropeptides: relevance in treatment of depression and anxiety disorders.
    Madaan V; Wilson DR
    Drug News Perspect; 2009; 22(6):319-24. PubMed ID: 19771321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropeptide receptor ligands as drugs for psychiatric diseases: the end of the beginning?
    Griebel G; Holsboer F
    Nat Rev Drug Discov; 2012 May; 11(6):462-78. PubMed ID: 22596253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypothalamic stress systems in mood disorders.
    Holsboer F; Ising M
    Handb Clin Neurol; 2021; 182():33-48. PubMed ID: 34266603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropeptide systems and schizophrenia.
    LaCrosse AL; Olive MF
    CNS Neurol Disord Drug Targets; 2013 Aug; 12(5):619-32. PubMed ID: 23574175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Behavioral effects of neuropeptides in rodent models of depression and anxiety.
    Rotzinger S; Lovejoy DA; Tan LA
    Peptides; 2010 Apr; 31(4):736-56. PubMed ID: 20026211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropeptides in anxiety modulation.
    Landgraf R
    Handb Exp Pharmacol; 2005; (169):335-69. PubMed ID: 16594264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of neuropeptides in anxiety, stress, and depression: from animals to humans.
    Kormos V; Gaszner B
    Neuropeptides; 2013 Dec; 47(6):401-19. PubMed ID: 24210138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antipsychotics and neuropeptides: the atypical profile of CI-943 and its relationship to neurotensin.
    Liégeois JF; Bonaventure P; Delarge J; Damas J
    Neurosci Biobehav Rev; 1995; 19(4):519-31. PubMed ID: 8684714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations in central neuropeptide expression, release, and receptor binding in rats bred for high anxiety: critical role of vasopressin.
    Wigger A; Sánchez MM; Mathys KC; Ebner K; Frank E; Liu D; Kresse A; Neumann ID; Holsboer F; Plotsky PM; Landgraf R
    Neuropsychopharmacology; 2004 Jan; 29(1):1-14. PubMed ID: 12942143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of neuropeptides in the regulation of adrenal zona glomerulosa function: effects of substance P, neuropeptide Y, neurotensin, Met-enkephalin, Leu-enkephalin and corticotrophin-releasing hormone on aldosterone secretion in the intact perfused rat adrenal.
    Hinson JP; Cameron LA; Purbrick A; Kapas S
    J Endocrinol; 1994 Jan; 140(1):91-6. PubMed ID: 7511155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurochemical regulation of sleep.
    Steiger A
    J Psychiatr Res; 2007 Oct; 41(7):537-52. PubMed ID: 16777143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Receptors of peptides as therapeutic targets in epilepsy research.
    Dobolyi A; Kékesi KA; Juhász G; Székely AD; Lovas G; Kovács Z
    Curr Med Chem; 2014; 21(6):764-87. PubMed ID: 24251562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurotensin: role in psychiatric and neurological diseases.
    Cáceda R; Kinkead B; Nemeroff CB
    Peptides; 2006 Oct; 27(10):2385-404. PubMed ID: 16891042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropeptide systems and new treatments for nicotine addiction.
    Bruijnzeel AW
    Psychopharmacology (Berl); 2017 May; 234(9-10):1419-1437. PubMed ID: 28028605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of corticotropin-releasing factor-like peptides in cannabis, nicotine, and alcohol dependence.
    Bruijnzeel AW; Gold MS
    Brain Res Brain Res Rev; 2005 Nov; 49(3):505-28. PubMed ID: 16269317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropeptides: opportunities for drug discovery.
    Hökfelt T; Bartfai T; Bloom F
    Lancet Neurol; 2003 Aug; 2(8):463-72. PubMed ID: 12878434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Arginine vasopressin is an important regulator in antinociceptive modulation of hypothalamic paraventricular nucleus in the rat.
    Yang J; Yang Y; Chen JM; Xu HT; Liu WY; Wang CH; Lin BC
    Neuropeptides; 2007 Jun; 41(3):165-76. PubMed ID: 17316791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.